DE2612760A1 - Cephalosporinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel - Google Patents

Cephalosporinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Info

Publication number
DE2612760A1
DE2612760A1 DE19762612760 DE2612760A DE2612760A1 DE 2612760 A1 DE2612760 A1 DE 2612760A1 DE 19762612760 DE19762612760 DE 19762612760 DE 2612760 A DE2612760 A DE 2612760A DE 2612760 A1 DE2612760 A1 DE 2612760A1
Authority
DE
Germany
Prior art keywords
group
compound
compound according
och
cooh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762612760
Other languages
German (de)
English (en)
Inventor
Charles Andrew Raymond Baxter
Braham Dr Shroot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7512813A external-priority patent/GB1542397A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE2612760A1 publication Critical patent/DE2612760A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
DE19762612760 1975-03-27 1976-03-25 Cephalosporinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel Pending DE2612760A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7512813A GB1542397A (en) 1975-03-27 1975-03-27 Cephem compounds
GB4393575 1975-10-24

Publications (1)

Publication Number Publication Date
DE2612760A1 true DE2612760A1 (de) 1976-10-07

Family

ID=26249284

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762612760 Pending DE2612760A1 (de) 1975-03-27 1976-03-25 Cephalosporinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Country Status (15)

Country Link
JP (1) JPS51138694A (pt)
AU (1) AU1244276A (pt)
DD (1) DD124601A5 (pt)
DE (1) DE2612760A1 (pt)
DK (1) DK132876A (pt)
ES (1) ES446353A1 (pt)
FI (1) FI760793A (pt)
FR (1) FR2305186A1 (pt)
IE (1) IE43541B1 (pt)
IL (1) IL49183A0 (pt)
LU (1) LU74651A1 (pt)
NL (1) NL7603116A (pt)
NO (1) NO761052L (pt)
PT (1) PT64951B (pt)
SE (1) SE7603699L (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA999574A (en) * 1972-06-14 1976-11-09 Smith Kline And French Canada Ltd. 7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins
PH16419A (en) * 1973-01-31 1983-09-29 Bristol Myers Co 7-(d-alpha-amino-alpha-(3'-methyl-4'-hydroxyphenyl)-acetamido)-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid,pharmaceutically acceptable esters and salts thereof
US3989694A (en) * 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Also Published As

Publication number Publication date
DK132876A (da) 1976-09-28
IL49183A0 (en) 1976-05-31
ES446353A1 (es) 1977-11-16
FR2305186B1 (pt) 1980-07-04
LU74651A1 (pt) 1977-10-10
IE43541B1 (en) 1981-03-25
FI760793A (pt) 1976-09-28
IE43541L (en) 1976-09-27
DD124601A5 (pt) 1977-03-02
JPS51138694A (en) 1976-11-30
FR2305186A1 (fr) 1976-10-22
SE7603699L (sv) 1976-09-28
PT64951B (en) 1977-08-26
NL7603116A (nl) 1976-09-29
NO761052L (pt) 1976-09-28
AU1244276A (en) 1977-10-06
PT64951A (en) 1976-04-01

Similar Documents

Publication Publication Date Title
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DE2462736B1 (de) 7-Aminothiazolylacetamido-3-cephem-4-carbonsaeuren und Verfahren zur Herstellung derselben
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
CH628058A5 (de) Verfahren zur herstellung von cephemverbindungen.
CH633558A5 (de) Verfahren zur herstellung neuer cephalosporinderivate.
DE2312042A1 (de) Cephalosporine und verfahren zu deren herstellung
AT369749B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
CH615931A5 (en) Process for the preparation of the syn isomer or of a mixture of syn and anti isomers, the content of the syn isomer being at least 90%, of 7-acylaminoceph-3-em-4-carboxylic acids
DE2052962A1 (pt)
CH641468A5 (de) Cephemderivate.
DE2222434C2 (de) Cephalosporin-Derivat und Verfahren zu dessen Herstellung
DE2217563A1 (de) Verfahren zur Herstellung von Acylaminoverbindungen
DE2056983A1 (de) Verfahren zur Herstellung von Acylamino verbindungen
DE2549608A1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2234280B2 (de) Cephalosporinverbindungen und Verfahren zu deren Herstellung
DE2203653A1 (de) Cephalosporincarbamate und Verfahren zu deren Herstellung
DE2612760A1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2805590A1 (de) Pharmakologisch wirksame cephalosporinsaeurederivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
DE2325065A1 (de) Neue dithiocarbonylaminoacetylcephalosporine
DE2655717A1 (de) Thiadiazolylderivate von 7-acylamido-3-cephem-4-carbonsaeure, verfahren zu deren herstellung und dieselben enthaltende pharmazeutische und veterinaermedizinische mittel
DE2336344A1 (de) Penicillin- und cephalosporin-rsulfoxide, ihre salze und ester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2727977C3 (de) 7α -Methoxycephalosporinderivate und sie enthaltende Arzneimittel
CH615186A5 (en) Process for the preparation of cephem compounds
CH634326A5 (de) 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung.
DE2545818A1 (de) Alpha-hydroxy-beta-aminopropionylcephalosporinderivate

Legal Events

Date Code Title Description
OHW Rejection